We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| XORTX Therapeutics Inc | CSE:XRX | CSE | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.80 | 3.24 | 24.00 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
Xerox Corp. (XRX) Chief Executive Anne Mulcahy said that customers have cut the amount of supplies they hold in inventory and won't be returning to those levels.
"We're not counting on a return to the past in any way," Mulcahy said in a conference call to discuss first-quarter earnings. "People are going to manage with less for some time to come."
On Friday, Xerox cut its full-year earnings target.
Mulcahy said that developing markets, especially Russia and Eurasia, had hurt business as customers are unable to access credit. However, she added that Xerox's leasing business in the U.S. and Western Europe "plays well in touch economic times," adding that they haven't moved to offer aggressive financing strategies such as no-interest leases.
Xerox shares were recently up 5.8% to $6.07.
-By Jerry A. DiColo; Dow Jones Newswires; 201-938-5670; jerry.dicolo@dowjones.com
1 Year XORTX Therapeutics Chart |
1 Month XORTX Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
